Brevan Howard Capital Management’s Insmed INSM Stock Holding History

Brevan Howard Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67M	Buy	15,677 +12,156	+345%	+$1.47M	0.01%	804
2026 Q1	$576K	Buy	+3,521	New	+$541K	0.01%	1213
2025 Q4	–	Sell	-294,047	Closed	-$42.3M	–	2037
2025 Q3	$42.3M	Buy	294,047 +91,453	+45%	+$11.2M	0.19%	45
2025 Q2	$20.4M	Buy	+202,594	New	+$15.5M	0.12%	88
2024 Q3	–	Sell	-6,127	Closed	-$411K	–	1284
2024 Q2	$411K	Sell	6,127 -18,446	-75%	-$715K	﹤0.01%	673
2024 Q1	$667K	Buy	24,573 +18,112	+280%	+$507K	0.01%	372
2023 Q4	$200K	Buy	+6,461	New	+$168K	﹤0.01%	885

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Brevan Howard Capital Management's INSM Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Insmed (INSM) stake by 345% in Q2 2026, buying an estimated $1.47M and bringing the position to 15,677 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #804.

Brevan Howard Capital Management first reported a position in INSM in Q4 2023 and has held it in 7 quarters since. The position peaked at $42.3M in Q3 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Brevan Howard Capital Management held 15,677 shares of Insmed worth $1.67M as of Q2 2026.
Brevan Howard Capital Management bought 12,156 Insmed shares in Q2 2026, an estimated $1.47M.
Insmed made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #804 holding.
Brevan Howard Capital Management first reported a position in Insmed in Q4 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Insmed position peaked at $42.3M in Q3 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.